Financhill
Back

Global Blood Therapeutics Stock Price Chart

Buy
51

GBT
Global Blood Therapeutics

Last Price:
68.10
Seasonality Move:
4.71%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GBT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Global Blood Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 67.98 Buy
20-day SMA: 67.91 Buy
50-day SMA: 60.97 Buy
200-day SMA: 37.77 Buy
8-day EMA: 68.01 Buy
20-day EMA: 67.28 Buy
50-day EMA: 60.53 Buy
200-day EMA: 43.43 Buy

Global Blood Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.66 Buy
Relative Strength Index (14 RSI): 74.92 Buy
Chaikin Money Flow: -861513 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.74 - 68.12) Buy
Bollinger Bands (100): (26.03 - 64.17) Buy

Global Blood Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Global Blood Therapeutics Stock

Is Global Blood Therapeutics Stock a Buy?

GBT Technical Analysis vs Fundamental Analysis

Buy
51
Global Blood Therapeutics (GBT) is a Buy

Is Global Blood Therapeutics a Buy or a Sell?

Global Blood Therapeutics Stock Info

Market Cap:
4.59B
Price in USD:
68.10
Share Volume:
2.58M

Global Blood Therapeutics 52-Week Range

52-Week High:
73.02
52-Week Low:
21.65
Buy
51
Global Blood Therapeutics (GBT) is a Buy

Global Blood Therapeutics Share Price Forecast

Is Global Blood Therapeutics Stock a Buy?

Fundamental Analysis of Global Blood Therapeutics

Is Global Blood Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and an increase next year of $1.88 per share.

Technical Analysis of Global Blood Therapeutics

Should I short Global Blood Therapeutics stock?

* Global Blood Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.